Background Reports have suggested that statin use is associated with an increased
incidence of type 2 diabetes mellitus (T2DM). Guidelines suggested that statins should be …

Background Statins have been known to increase the risk of incident type 2 diabetes
mellitus (DM); however, other factors, especially hypertension, are also associated with DM …

Background The aim of this study was to investigate the association between statin use and
new-onset diabetes in clinical settings and to assess its effect modification (heterogeneity) …

Background Cardiovascular disease (CVD) is the major cause of death among persons with
diabetes. As the preventative use of statin has been proved to reduce CVD risks …

Although concern regarding the increased risk for new-onset diabetes mellitus (NODM) after
statin treatment has been raised, there has been a lack of evidence in real-world clinical …

Statin therapy is beneficial in reducing cardiovascular events and mortalities in patients with
atherosclerotic cardiovascular diseases. Yet, there have been concerns of increased risk of …

Background Statins reduce cardiovascular risks but increase the risk of new-onset diabetes
(NOD). The aim of this study is to determine what effect, if any, statins have on the risk of …

Background Several studies suggest that statin may increase the risk of new-onset diabetes
mellitus (NODM). This study aimed to evaluate the association between the duration and …

Background There is strong evidence of reductions in major vascular events from statins
across all cardiovascular risk categories. However, trials of statin therapy have provided …

BACKGROUND: Statins have been linked to new-onset diabetes (NOD); however, the effect
of statins on the development of NOD in patients with hypertension and dyslipidemia has not …